The Venture Codex Logo

The Venture Codex

Lilly Ventures

333 N Alabama St, Ste 350, Indianapolis, IN, 46204, United States

Overview

Venture capital firm investing in life sciences and supporting startups.

Founded

2001

Deals ยท 12mo

1

Links

Website

Stage focus

Multi-stage

Geographic focus

Australia
United States

Sector focus

Financial Services
Impact Investing
Innovation Management
Life Science
...

Investment portfolio

35rounds
NAMEDATESIZE
NewLimit
Jun 2026Participated
$435 MSeries C
BioAge Labs
Feb 2024Participated
$170 MSeries D
BioAge
Feb 2024Participated
$170 MSeries D
Sutro Biopharma
Jul 2018Participated
$85 MSeries E
Nimbus Therapeutics
Jun 2018Participated
$65 MOther Equity
Kymera Therapeutics
Oct 2017Participated
$30 MSeries A
Cavion
Jan 2017Led
$26 MSeries A
Symic Biomedical
Dec 2015Led
$25 MSeries A
Protagonist Therapeutics
Jul 2015Participated
$40 MSeries C
Innocrin Pharmaceuticals
Apr 2015Participated
$28 MSeries D
Aeglea BioTherapeutics
Mar 2015Led
$44 MSeries B
Nimbus Therapeutics
Mar 2015Participated
$43 MSeries B
NewLimit
Jun 2026Participated
$435 MSeries C
BioAge Labs
Feb 2024Participated
$170 MSeries D
BioAge
Feb 2024Participated
$170 MSeries D
Sutro Biopharma
Jul 2018Participated
$85 MSeries E
Nimbus Therapeutics
Jun 2018Participated
$65 MOther Equity
Kymera Therapeutics
Oct 2017Participated
$30 MSeries A
Cavion
Jan 2017Led
$26 MSeries A
Symic Biomedical
Dec 2015Led
$25 MSeries A
Protagonist Therapeutics
Jul 2015Participated
$40 MSeries C
Innocrin Pharmaceuticals
Apr 2015Participated
$28 MSeries D
Aeglea BioTherapeutics
Mar 2015Led
$44 MSeries B
Nimbus Therapeutics
Mar 2015Participated
$43 MSeries B
35
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Lilly Ventures: 35 funding rounds are recorded in the selected participation categories.All available history.
Lilly Ventures: 35 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A53
Series B24
Series C+115
Other Equity13

Monthly Deal Activity

Lilly Ventures: 35 deals are recorded across 204 months.All available history.
Lilly Ventures: 35 deals are recorded across 204 months. All available history
MonthDeals
Nov '091
Dec '091
Jan '100
Feb '100
Mar '100
Apr '101
May '100
Jun '100
Jul '101
Aug '100
Sep '101
Oct '100
Nov '102
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '111
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '111
Jan '120
Feb '121
Mar '121
Apr '120
May '121
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '131
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '131
Dec '131
Jan '140
Feb '140
Mar '140
Apr '140
May '142
Jun '141
Jul '140
Aug '140
Sep '140
Oct '142
Nov '140
Dec '140
Jan '152
Feb '151
Mar '152
Apr '151
May '150
Jun '150
Jul '151
Aug '150
Sep '150
Oct '150
Nov '150
Dec '151
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '171
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '171
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '181
Jul '181
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Lilly Ventures: Health & Life Sciences is the largest displayed sector by deal count (35 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Lilly Ventures: Health & Life Sciences is the largest displayed sector by deal count (35 deals). All available history
SectorDeals
Health & Life Sciences35
Data, Analytics & IT2
Space & Frontier Tech2
AI & Machine Learning1
Social & Community Platforms1
Consumer & Lifestyle1

Deal Size Distribution

Lilly Ventures: 35 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Lilly Ventures: 35 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M10
$25M-$50M14
$50M-$100M5
$100M-$250M2
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Lilly Ventures: United States has the largest recorded deal count among the displayed regions (33 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Lilly Ventures: United States has the largest recorded deal count among the displayed regions (33 deals). All available history
RegionDeals
United States33
Australia2
Lilly Ventures: 20 co-investors are shown, with Novartis sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Lilly Ventures: 20 co-investors are shown, with Novartis sharing 9 recorded deals. All available history
Co-investorShared deals
Novartis9
Amgen Ventures8
Atlas Venture8
SR One6
SV Health Investors6
Venrock6
RA Capital Management5
Roche Venture5
Alta Partners4
Hatteras Venture Partners4
Skyline Ventures4
Aberdare Ventures3
Apple Tree Partners3
De Novo Ventures3
Excel Venture Management3
Forward Ventures3
OrbiMed3
Polaris Partners3
Sofinnova Ventures3
Ally Bridge Group2

Investment Strategy

Lilly Ventures: Led accounts for 26% and participating for 74% of round participation.All available history.
Lilly Ventures: Led accounts for 26% and participating for 74% of round participation. All available history
CategoryDeals (count)Share (%)
Led926%
Participating2674%
Lilly Ventures: Single-lead accounts for 44% and co-led for 56% of lead dynamics.All available history.
Lilly Ventures: Single-lead accounts for 44% and co-led for 56% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead444%
Co-led556%

Team

Lisa Belas

Office Manager

Steve Hall

Venture Partner